Laurus Labs Stock

Laurus Labs EBITDA per Employee

The EBITDA per Employee of Laurus Labs (LAURUSLABS.NS) as of Aug 7, 2026 is 2.06 M INR. In the previous year, EBITDA per Employee was 1.52 M INR — a change of 35.39% (higher).

EBITDA per Employee

2.06 MINR

YoY

35.39%

Last updated:

EBITDA per Employee of Laurus Labs is 2026 2.06 M INR. EBITDA per Employee of Laurus Labs was 2025 1.52 M INR. It decreases by 35.39% higher compared to the previous year.
Access this data via the Eulerpool API

Laurus Labs Stock analysis

What does Laurus Labs do? Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Since its establishment in 2005, the company has become one of the leading providers of API products on the global market. Answer: Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Laurus Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laurus Labs stock

EBITDA per Employee of Laurus Labs is 2.06 M INR in 2026.

EBITDA per Employee of Laurus Labs changed from 1.52 M INR to 2.06 M INR, representing a 35.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Laurus Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Laurus Labs historically and in real time.

Access this data via the Eulerpool API

Workforce — Laurus Labs

All Key Metrics — Laurus Labs